What pharmacologic treatment is recommended for an adult with chronic idiopathic (subjective) tinnitus?

Pharmacotherapy for Chronic Idiopathic Tinnitus

Do not routinely prescribe antidepressants, anticonvulsants, anxiolytics, intratympanic medications, or dietary supplements for chronic idiopathic tinnitus—these medications lack sufficient evidence for efficacy and carry significant risks of adverse effects including paradoxically worsening tinnitus. 1, 2

The Evidence Against Pharmacotherapy

The most authoritative guidance comes from the American Academy of Otolaryngology-Head and Neck Surgery Foundation's 2014 and 2026 clinical practice guidelines, which make strong recommendations against routine pharmacological treatment for persistent, bothersome tinnitus 1, 2. This recommendation is based on:

• Grade B evidence from systematic reviews and RCTs demonstrating low strength of evidence for efficacy
• Significant potential for adverse effects, including the ironic possibility that some medications (particularly antidepressants) may actually worsen tinnitus
• Unjustified cost and false hope when evidence doesn't support benefit
• Lack of FDA approval for these medications in treating tinnitus, especially problematic in geriatric populations 1

Specific Medications to Avoid

The guidelines explicitly recommend against the following:

• Antidepressants (including amitriptyline, despite some research suggesting benefit)
• Anticonvulsants (including gabapentin)
• Anxiolytics (benzodiazepines)
• Intratympanic medications (including dexamethasone)
• Dietary supplements: Ginkgo biloba, melatonin, zinc 1, 2

The Research-Guideline Discordance

A 2021 network meta-analysis 3 suggested that amitriptyline, acamprosate, gabapentin, and intratympanic dexamethasone plus oral melatonin showed superior improvement in tinnitus severity compared to placebo. However, this research evidence must be subordinated to the guideline recommendations because:

1. The guidelines explicitly acknowledge that some studies show benefit but conclude the evidence is insufficient to justify routine use given known harms
2. The RCTs have significant methodological concerns, bias, and lack of statistical power
3. The risk-benefit analysis favors avoiding these medications in routine practice 1

What Should Be Done Instead

First-Line Interventions (Evidence-Based)

Cognitive Behavioral Therapy (CBT) is the only intervention with a strong positive recommendation for persistent, bothersome tinnitus 1, 2. This is based on RCTs showing preponderance of benefit over harm.

Audiologic Interventions

For patients with hearing loss and tinnitus:

• Hearing aid evaluation is recommended (not optional) 1, 2
• Benefits extend even to mild hearing loss or unilateral sensorineural hearing loss
• Hearing aids may improve tinnitus even in marginal hearing aid candidates

For patients meeting cochlear implant criteria:

• Refer for cochlear implant evaluation 2

Sound Therapy

Clinicians may recommend sound enrichment to patients with persistent, bothersome tinnitus 2. This is an option-level recommendation, meaning it's reasonable but not mandatory.

Emerging Options

Bimodal neuromodulation may be offered as an option 2, though this is a newer intervention with less established evidence than CBT.

Common Pitfalls to Avoid

1. Don't prescribe medications just because patients request them or because "nothing else works"—the evidence shows these medications don't work reliably and carry real risks
2. Don't assume sulodexide or transdermal lidocaine are viable alternatives 4, 5—these small pilot studies don't override guideline recommendations
3. Don't order imaging routinely—imaging is only indicated for unilateral tinnitus, pulsatile tinnitus, focal neurologic abnormalities, or asymmetric hearing loss 2

The Bottom Line Algorithm

For an adult with chronic idiopathic (subjective) tinnitus:

1. Perform comprehensive audiologic evaluation 2
2. If hearing loss present: Recommend hearing aid evaluation 2
3. For persistent, bothersome tinnitus: Recommend CBT 1, 2
4. Consider: Sound enrichment as adjunct 2
5. Do NOT prescribe: Antidepressants, anticonvulsants, anxiolytics, intratympanic medications, or supplements 1, 2

The guideline's value judgment is clear: although some pharmacologic therapies appear beneficial in flawed studies, the evidence is insufficient to justify routine use given known harms, costs, and potential for worsening tinnitus 1.